Skip to content

Effect of Non-essential Amino Acids on Protein Requirements for Endurance Athletes

Effect of Non-essential Amino Acids on Protein Requirements for Endurance Athletes Using Indicator Amino Acid Oxidation Method.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02874638
Acronym
EA3
Enrollment
7
Registered
2016-08-22
Start date
2016-09-30
Completion date
2017-12-31
Last updated
2019-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy, Increased Metabolic Requirement

Brief summary

Protein requirements in individuals who participate in endurance-based exercise training have been suggested to be greater than the current recommended dietary allowance (RDA). The biological value of protein depends on its amino acid composition. Essential amino acids are believed to have main role on whole body protein metabolism. However, it remains to be determined what role non-essential amino acids (NEAA) may have in regulating protein metabolism and contributing to the increased protein requirements after endurance exercise. The indicator amino acid oxidation (IAAO) method has clarified the individual amino acid requirement in children, normal healthy adult and clinical populations. However, the IAAO method has never been utilized for assessing the effect of NEAA on protein requirements after endurance exercise. The objective of the current study is to investigate the importance of NEAA for endurance-trained male subjects.

Interventions

DIETARY_SUPPLEMENTBASE egg protein

0.8 g/kg/d of protein provided as crystalline amino acid modeled after egg protein

DIETARY_SUPPLEMENTBCAA-enriched egg protein

BCAA-enriched egg protein provided as crystalline amino acid.

DIETARY_SUPPLEMENTsmall amount of essential amino acids

essential amino acids modeled after egg protein, provided as crystalline amino acid, which is equivalent to the amount of essential amino acid in BASE egg protein

DIETARY_SUPPLEMENTlarge amount of essential amino acids

essential amino acids modeled after egg protein, provided as crystalline amino acid, which is equivalent to the amount of amino acid in BCAA-enriched egg protein

Sponsors

Ajinomoto Co., Inc.
CollaboratorINDUSTRY
University of Toronto
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
MALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* endurance-trained participants who regularly run more than 40 km/week * Participants who are categorized at least very good based on a study by Shvartz & Reibold, in which VO2peak is used as an index. (i.e. the participants whose VO2peak is ≥57 ml/kg/min (18-24 y), ≥54 ml/kg/min (25-29 y), ≥52 ml/kg/min (30-34 y), ≥49 ml/kg/min (35-39 y) * Ability to complete the 16-km familiarization run in session 2

Exclusion criteria

* Inability to meet health and physical activity guidelines according to the physical activity readiness questionnaire (PAR-Q+) * Inability to adhere to any of the protocol guidelines (i.e. alcohol, caffeine consumption) * Regular tobacco use * Illicit drug use

Design outcomes

Primary

MeasureTime frameDescription
13CO2 (carbon dioxide) excretion rate (μmol/kg/h)at 8 hours after the end of exercise]8 hours after exercise followed by ingesting 13C-labelled phenylalanine and one of 5 different amount of amino acids intake, 13CO2 excretion rate is determined by multiplying the enrichment of 13CO2 in breath measured by Mass spectrometry and CO2 production rate measured by metabolic cart.

Secondary

MeasureTime frameDescription
[13C]phenylalanine oxidation rate (μmol/kg/h)at 8 hours after the end of exercise8 hours after exercise followed by ingesting 13C-labelled phenylalanine and one of 5 different amount of amino acids intake, 13CO2 excretion rate is determined dividing 13CO2 excretion rate by urinary enrichment of 13C-phenylalanine in breath measured by Mass spectrometry, and CO2 production rate measured by metabolic cart.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026